Allico Pharmaceutical Decides to Acquire Treasury Shares Worth 4.7 Billion KRW
[Asia Economy Reporter Minwoo Lee] Aliko Pharmaceutical announced on the 6th that it has decided to acquire 64,000 shares of its common stock worth 4.7 billion KRW on the market. The expected acquisition period is from the 7th to January 6, 2022. The company explained, "We decided to acquire treasury shares to stabilize the stock price and enhance shareholder value."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Musinsa Issues Second Apology for 2019 'Park Jongcheol Advertisement Controversy'... "A Stern Lesson"
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
